L1 Capital Pty Ltd sold 208,731 shares of $AVR (Anteris Technologies Global Corp.) on July 28, 2026, at an average price of $8.09 per share, generating approximately $1.69 million. The transaction was an open-market sale. A Form 4 covering it was filed the following day.
The July 28 disposal was the third such transaction L1 Capital recorded in five trading days. On July 24, the Sydney-based firm sold 23,000 shares at $8.13 per share, totaling roughly $187,000. Three days later, on July 27, it sold a larger block of 232,817 shares at $8.19 per share for approximately $1.91 million. Across the three transactions, L1 Capital sold 464,548 shares and collected roughly $3.78 million in total proceeds. After the July 28 sale, its reported position in Anteris stood at 7,347,452 shares.
The most recent disclosed activity before this sequence ran in the opposite direction. On January 22, 2026, L1 Capital purchased 5,000,000 shares at $5.75 per share in a transaction valued at $28.75 million; the filing for that purchase was submitted on February 9, 2026. A separate Form 4 filed on July 28 also reflects a January 22 purchase of 5,000,000 shares at the same price and total value, with an associated reported holding of 7,812,000 shares.
$AVR shares closed at $8.17 on July 28, matching the closing price from the prior session on July 27. The stock opened that day at $8.15, reached an intraday high of $8.43, and dipped to a low of $7.75. Volume came in at approximately 1.5 million shares, meaningfully higher than in either of the two preceding sessions.
Anteris Technologies Global Corp. is classified in the Health Care sector. No congressional STOCK Act disclosures for $AVR are present in the database. L1 Capital is an entity filer — an investment firm rather than an individual — and holds the status of a principal shareholder under SEC reporting rules, which triggers Form 4 obligations for open-market transactions.